Trial NCT04624113

View at ClinicalTrials.gov 
Org. Study IDs: 202011174

Last trial update was posted on 2024-02-21

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Head and Neck Squamous Cell Carcinoma

Stopping Reasons

Ipsen bought out Epizyme

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID